|
DPF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.790200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.988400E-01 |
| Normal-vs-Stage2 |
6.944000E-01 |
| Normal-vs-Stage3 |
1.872170E-01 |
| Normal-vs-Stage4 |
8.747000E-01 |
| Stage1-vs-Stage2 |
9.933800E-01 |
| Stage1-vs-Stage3 |
1.227950E-02 |
| Stage1-vs-Stage4 |
4.856600E-01 |
| Stage2-vs-Stage3 |
1.062010E-01 |
| Stage2-vs-Stage4 |
6.132600E-01 |
| Stage3-vs-Stage4 |
2.810400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.203400E-01 |
| Normal-vs-AfricanAmerican |
5.450800E-01 |
| Normal-vs-Asian |
1.157840E-01 |
| Caucasian-vs-AfricanAmerican |
5.428200E-01 |
| Caucasian-vs-Asian |
9.294400E-02 |
| AfricanAmerican-vs-Asian |
5.705400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.603000E-01 |
| Normal-vs-Female |
9.549000E-01 |
| Male-vs-Female |
8.769600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.278800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.765000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.291960E-01 |
| Normal-vs-Age(81-100Yrs) |
2.900400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.220000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.997500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.409530E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608190E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.146000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.864150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.079700E-03 |
| Classical-VS-Follicular |
5.396000E-03 |
| Classical-VS-Other |
5.968800E-01 |
| Classical-VS-Normal |
2.996000E-01 |
| Tall-VS-Follicular |
5.593800E-01 |
| Tall-VS-Other |
4.101200E-01 |
| Tall-VS-Normal |
9.098400E-02 |
| Follicular-VS-Other |
6.559800E-01 |
| Follicular-VS-Normal |
2.244800E-01 |
| Other-VS-Normal |
9.222400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.701400E-01 |
| Normal-vs-N1 |
1.613600E-01 |
| N0-vs-N1 |
1.105440E-01 |
|
|
